Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Almasio

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Viral Hepatitis|April 23, 2014
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trialP Colombatto, M R Brunetto, A M Maina, et al.
The American Journal of Gastroenterology|July 1, 1998
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)G Fattovich, G Giustina, J Sanchez-Tapias, et al.
Journal of Hepatology|November 1, 1996
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy)S Magrin, A Craxi, C Fabiano, et al.
Journal of Viral Hepatitis|June 26, 2001
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in EuropeG Fattovich, M L Ribero, M Pantalena, et al.
Gastroenterology|February 1, 1997
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsG Fattovich, G Giustina, F Degos, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Viral Hepatitis|April 23, 2014
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trialP Colombatto, M R Brunetto, A M Maina, et al.
The American Journal of Gastroenterology|July 1, 1998
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)G Fattovich, G Giustina, J Sanchez-Tapias, et al.
Journal of Hepatology|November 1, 1996
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy)S Magrin, A Craxi, C Fabiano, et al.
Journal of Viral Hepatitis|June 26, 2001
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in EuropeG Fattovich, M L Ribero, M Pantalena, et al.
Gastroenterology|February 1, 1997
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsG Fattovich, G Giustina, F Degos, et al.
Pageof 7